Publicacións nas que colabora con Tomas Sobrino Moreiras (22)

2018

  1. Sevoflurane but not Propofol Induces Immunomodulatory Effects in Patients Undergoing Aortic Valve Replacement and Cardiopulmonary Bypass

    International Journal of Anesthetics and Anesthesiology, Vol. 5, Núm. 1

2016

  1. Neuroprotective effects of dexmedetomidine conditioning strategies: Evidences from an in vitro model of cerebral ischemia

    Life Sciences, Vol. 144, pp. 162-169

2013

  1. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator

    Atherosclerosis, Vol. 226, Núm. 1, pp. 165-171

2011

  1. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke

    Journal of Translational Medicine, Vol. 9

  2. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke

    Neurological Research, Vol. 33, Núm. 6, pp. 572-577

  3. Imaging techniques for studying functional recovery following a stroke: II. Complementary techniques

    Revista de Neurologia, Vol. 52, Núm. 7, pp. 417-425

  4. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental study

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1378-1386

  5. Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA

    Neurochemistry International, Vol. 58, Núm. 3, pp. 337-343

  6. Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients

    Neurological Research, Vol. 33, Núm. 10, pp. 1057-1063

  7. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

  8. Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

    Clinical Immunology, Vol. 139, Núm. 2, pp. 193-198

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

  2. Proteomic analysis of the tear film in patients with keratoconus

    Molecular Vision, Vol. 16, pp. 2055-2061

2009

  1. High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage

    Journal of Cerebral Blood Flow and Metabolism, Vol. 29, Núm. 12, pp. 1968-1974

  2. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke

    Disease Markers, Vol. 26, Núm. 4, pp. 189-195

  3. Plasma β-amyloid 1-40 is associated with the diffuse small vessel disease subtype

    Stroke, Vol. 40, Núm. 10, pp. 3197-3201

  4. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke

    Clinical Chemistry and Laboratory Medicine, Vol. 47, Núm. 12, pp. 1513-1518

  5. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation

    Atherosclerosis, Vol. 205, Núm. 2, pp. 561-567

2008

  1. Marcadores moleculares asociados a signos precoces de isquemia en tomografía computarizada cerebral

    Neurologia, Vol. 23, Núm. 4, pp. 220-225

  2. Statins and stroke

    Therapeutic Advances in Cardiovascular Disease, Vol. 2, Núm. 3, pp. 157-166